Company Overview and News

3
Indiabulls Housing Finance raises Rs 2,318 cr via bonds

2018-06-15 moneycontrol
Indiabulls Housing Finance has raised Rs 2,318.50 crore by issuing bonds on a private placement basis. This is part of the company's Rs 24,000 crore fund raise plan. Indiabulls Housing Finance had announced to raise Rs 24,000 crore by way of issuance of secure, redeemable, non-convertible debentures on private placement basis in December 2017.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

12
Market Update: Nifty pharma continues to rally as Dr Reddy#39;s jumps 3%; RIL hits record high

2018-06-15 moneycontrol
The broader indices are trading on a flat to positive note this Friday morning with the Nifty up 19 points at 10,822 and the Sensex is up 47 points at 35,647.
500325 UBL RELIANCE IDKQY UBHOLDINGS TCHQY TTNQY 532755 UNBWY 532478 TECHM 535789 IBULHSGFIN 532540 BAJFINANCE INOXWIND RIGD BJJQY TCS 507458 539083 500034 RLNIY

47
Forbes list: 5th biggest consumer financial services company

2018-06-14 freepressjournal.in
New York : Housing finance major HDFC has been ranked as the fifth biggest public company globally in the ‘consumer financial services category’ on a list compiled by Forbes magazine. American Express has topped this category, while Indiabulls Housing Finance is the only other Indian company (at 13th place) on the list. In the consumer financial services category, HDFC’s rank has moved up from 7th place last year.
COF.PRG COF.PRH DFS COF-P 500325 RELIANCE COF.WS IDKQY COF.PRP COF SYF COF-D DFS.PRB DFS.PRBCL 535789 IBULHSGFIN COF-C COF-F RIGD COF.PRC COF.PRD COF.PRF RLNIY

15
Market Update: Nifty pharma outperforms led by Aurobindo Pharma; PSU banks drag

2018-06-14 moneycontrol
The broader indices are trading on a negative note this Thursday afternoon with the Nifty shedding 67 points at 10,789 and the Sensex is down 200 points at 35,539.
GRASIM 500325 AUROPHARMA RELIANCE TCHQY 532755 511389 VIDEOIND TTNQY 535789 532540 532461 532483 RIGD HDFCBANK GAILF TV18BRDCST RLNIY SBAZ UBNC GRSJY JAGRAN 524804 IDKQY 532705 532800 TECHM CNRYY IBULHSGFIN GRSXY PNJZY HDB 500180 ARBQY GAILY 500300 TCS PNB CANBK

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Record Date

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Record Date

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Housing finance cos correct on margin concerns

2018-06-08 thehindubusinessline
Shares prices of housing finance companies have been correcting on margin concerns due to rising bond yields.
535789 IBULHSGFIN LICHSGFIN IDKQY LHFLY 500253

Related Articles

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

STML: Stemline Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...